Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Ludovico Cantuti‐Castelvetri(German Center for Neurodegenerative Diseases), Ravi Ojha(University of Helsinki), Liliana D. Pedro(German Center for Neurodegenerative Diseases), Minou Djannatian(German Center for Neurodegenerative Diseases), Jonas Franz(Universitätsmedizin Göttingen), Suvi Kuivanen(University of Helsinki), Franziska van der Meer(Universitätsmedizin Göttingen), Katri Kallio(University of Helsinki), Tuğberk Kaya(German Center for Neurodegenerative Diseases), Maria Anastasina(University of Helsinki), Teemu Smura(University of Helsinki), Lev Levanov(University of Helsinki), Leonóra Szirovicza(University of Helsinki), Allan Tobi(University of Tartu), Hannimari Kallio‐Kokko(University of Helsinki), Pamela Österlund(Finnish Institute for Health and Welfare), Merja Joensuu(The University of Queensland), Frédéric A. Meunier(The University of Queensland), Sarah J. Butcher(University of Helsinki), Martin Sebastian Winkler(Universitätsmedizin Göttingen), Brit Mollenhauer(Universitätsmedizin Göttingen), Ari Helenius(ETH Zurich), Özgün Gökçe(LMU Klinikum), Tambet Teesalu(University of Helsinki), Jussi Hepojoki(University of Zurich), Olli Vapalahti(University of Helsinki), Christine Stadelmann(Universitätsmedizin Göttingen), Giuseppe Balistreri(University of Helsinki), Mikael Simons(German Center for Neurodegenerative Diseases)
Science
October 20, 2020
Cited by 2,028Open Access
Full Text

Abstract

Another host factor for SARS-CoV-2 Virus-host interactions determine cellular entry and spreading in tissues. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the earlier SARS-CoV use angiotensin-converting enzyme 2 (ACE2) as a receptor; however, their tissue tropism differs, raising the possibility that additional host factors are involved. The spike protein of SARS-CoV-2 contains a cleavage site for the protease furin that is absent from SARS-CoV (see the Perspective by Kielian). Cantuti-Castelvetri et al. now show that neuropilin-1 (NRP1), which is known to bind furin-cleaved substrates, potentiates SARS-CoV-2 infectivity. NRP1 is abundantly expressed in the respiratory and olfactory epithelium, with highest expression in endothelial and epithelial cells. Daly et al. found that the furin-cleaved S1 fragment of the spike protein binds directly to cell surface NRP1 and blocking this interaction with a small-molecule inhibitor or monoclonal antibodies reduced viral infection in cell culture. Understanding the role of NRP1 in SARS-CoV-2 infection may suggest potential targets for future antiviral therapeutics. Science , this issue p. 856 , p. 861 ; see also p. 765


Related Papers

No related papers found

Powered by citation graph analysis